Quick Answer
Biomea Fusion, Inc. reported Cash and Equivalents of $55.81 million for fiscal year 2025.
Biomea Fusion, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $55.81M | -4.2% |
| 2024 | $58.28M | -67.0% |
| 2023 | $176.87M | +58.1% |
| 2022 | $111.90M | -23.2% |
| 2021 | $145.74M | +136.2% |
| 2020 | $61.70M | +25713.8% |
| 2019 | $239.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $46.64M | -47.0% | -17.0% |
| June 30, 2025 | $56.22M | -50.4% | +56.8% |
| March 31, 2025 | $35.86M | -75.3% | -38.5% |
| December 31, 2024 | $58.28M | -67.0% | -33.7% |
| September 30, 2024 | $87.95M | -55.8% | -22.4% |
| June 30, 2024 | $113.29M | -49.2% | -21.8% |
| March 31, 2024 | $144.92M | +67.9% | -18.1% |
| December 31, 2023 | $176.87M | +58.1% | -11.2% |
- Biomea Fusion, Inc. showed a decrease of -4.2% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, Biomea Fusion, Inc.’s cash and equivalents has grown by 23252.3% (from $239.0 thousand to $55.81 million).
- The most recent figure is from Biomea Fusion, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: